Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart drug tested to shield vessels from reflow damage

NCT ID NCT07192744

Summary

This small study tested whether a drug called rotigaptide could protect blood vessels from damage that sometimes occurs when blood flow returns after being blocked. Researchers enrolled 12 healthy, non-smoking men to measure blood flow in their forearms after creating a temporary blockage. The goal was to understand if this drug might help prevent vessel damage in heart conditions.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHAEMIC HEART DISEASES are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Edinburgh, 49 Little France Crescent

    Edinburgh, EH16 4SB, United Kingdom

Conditions

Explore the condition pages connected to this study.